A preclinical and clinical study to determine the efficacy of Neelkanthi Churna in management of Madhumeha w.s.r to Type 2 Diabetes Mellitus

Principal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1) Patients of either sex aged between 20-70yrs.
•2) Newly diagnosed patients of Type 2 Diabetes Mellitus having glycosylated Hb (HbA1C) between 6.5% to 10%
•3) Patients willing to participate in the trial.

•Subject of Type-1 DM or Type-2 DM on insulin/OHAÃ¢â?¬•s other than Metformin/ any other medication for glucose control in the last 3 months
•Subjects suffering from the complications of Diabetes Mellitus viz., diabetic neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent treatment.
•Patients having major medical illness like cancer, concurrent infection like tuberculosis.
•Patients with uncontrolled Hypertension.
•Patients with established diagnosis of CAD or any other clinically significant cardiovascular disease.
•Renal dysfunction (defined by eGFR < 60ml/min calculated by MDRD calculator)
•Subjects who have completed participation in any other clinical trial during the past 3 months.
•Any other condition which the investigator thinks may compromise the safety of subject.
•Subjects with Haemoglobin percentage < 9gm% for males and < 8gm%for females.

发起方